SCHEMBL24916028

SCHEMBL24916028

CCc1cc(C(=O)NCCNC(=O)c2ccncc2)c2nccc(C(C)C)c2c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.42
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EPHX2 P34913 1/20 0.40
RAB9A P51151 2/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DGAT1 O75907 1/20 0.37
GAA P10253 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24916013 0.88 MAP4K4 (0.40) L3MBTL1KMT2AMEN1EGLN1
SCHEMBL24915532 0.87 LMNA (0.48) TSHRRAB9ALMNAMAPTNPC1
SCHEMBL24915997 0.87 GPR52 (0.39) KMT2AMEN1MAPTEGLN1
SCHEMBL24916021 0.85 KMT2A (0.45) RAB9AKMT2AMEN1LMNANPC1
SCHEMBL24916033 0.84 RAB9A (0.43) RAB9AKMT2ACYP1A2LMNANPC1
SCHEMBL24916193 0.83 CSF1R (0.38) KMT2AMAPTNPC1SMN1; SMN2GAA
SCHEMBL24915849 0.82 PLK1 (0.37) L3MBTL1RAB9ACYP1A2LMNANPC1
SCHEMBL24916012 0.82 EGLN1 (0.34) KMT2AMEN1EGLN1
SCHEMBL24915710 0.82 KDM5A (0.40) KMT2AMAPTNPC1SMN1; SMN2GAA
SCHEMBL29923470 0.78 EGLN1 (0.51) NAAAL3MBTL1EPHX2RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 NAAA 2870/4885TSHR 4798/4885L3MBTL1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.